RNS Number : 5400ABreedon Group PLC24 May 2023


24 May 2023

BREEDON GROUP plc

(the "Company")

Director / PDMR Dealings

The Company has been notified that on 23 May 2023 Clive Watson, Non-executive Director of Breedon Group plc and a Person Discharging Managerial Responsibilities, bought 7,380 shares of 140p each in the Company ('Ordinary Shares'), at a price of 342.16p per Ordinary Share. 

Enquiries:

Breedon Group plc                                          www.breedongroup.com 

Susan Bolton, Deputy Company Secretary      01332 981215

Louise Turner-Smith, Head of Investor Relations      07860 911909

MHP (Public Relations Adviser)                     020 3128 8613

Reg Hoare

Rachel Farrington

Charles Hirst



Notification and public disclosure of transactions by persons discharging managerial

responsibilities and persons closely associated with them

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Clive Watson

2

Reason for the notification

a)

Position/status

Non-executive Director and PDMR

b)

Is this an initial notification or an amendment to a prior notification?

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Breedon Group plc

b)

LEI

213800DQGNQE3X76WS92

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 140p each

GB00BM8NFJ84

b)

Nature of the transaction

Purchase of Ordinary Shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

£3.4216 per share

7,380

d)

Aggregated information (if any)

- Aggregated volume

- Price

7,380

£25,251.41

e)

Date of transaction

23 May 2023

f)

Place of the transaction

London Stock Exchange plc

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. ENDDSHSEDFFLEDSEDI



Supplied Euroland.com - Privacy Policy